SCHEMBL16559092

SCHEMBL16559092

CCN(CC)c1cccc2c1Cc1ccccc1-2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.49
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
HTR7 P34969 5/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
HTR2B P41595 1/20 0.37
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
PGR P06401 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16577687 0.93 PNMT (0.46) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL16577686 0.89 PNMT (0.43) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL8760303 0.87 PNMT (0.46) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL27836591 0.84 PNMT (0.44) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL1930284 0.83 PNMT (0.43) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL16577693 0.82 PNMT (0.49) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL28794932 0.82 PNMT (0.42) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL27854621 0.82 PNMT (0.42) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL27836596 0.82 PNMT (0.42) PNMTNPC1RAB9AHTR7CYP1A2
SCHEMBL26687696 0.81 MAP3K9 (0.33) PNMTNPC1RAB9ADDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118489617-A Construction method of metabolism-related fatty liver disease model animal model 南通大学 2024-08-16 CN claimed
CN-118489617-A Construction method of metabolism-related fatty liver disease model animal model 南通大学 2024-08-16 CN disclosed
US-20180066000-A1 Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes MERCK PATENT GMBH (DE) 2018-03-08 US disclosed
US-20170365786-A1 COMPOSITIONS COMPRISING AT LEAST ONE POLYMER AND AT LEAST ONE METAL COMPLEX AND TO ELECTROLUMINESCENT DEVICES CONTAINING SAID COMPOSITIONS MERCK PATENT GMBH (DE) 2017-12-21 US disclosed
US-20170365785-A1 COMPOSITIONS COMPRISING AT LEAST ONE POLYMER AND AT LEAST ONE SALT, AND ELECTROLUMINESCENT DEVICES CONTAINING SAID COMPOSITIONS MERCK PATENT GMBH (DE) 2017-12-21 US disclosed
US-9815940-B2 Polymers containing substituted triarylamine units and electroluminescent devices containing said polymers MERCK PATENT GMBH (DE) 2017-11-14 US disclosed
CN-106233302-A Optical information code read method 株式会社理光 2016-12-14 CN disclosed
CN-106133042-A Ultrahigh molecular weight polyethylene stretching micro-porous film 东曹株式会社 2016-11-16 CN disclosed
US-20150069303-A1 POLYMERS CONTAINING SUBSTITUTED TRIARYLAMINE UNITS AND ELECTROLUMINESCENT DEVICES CONTAINING SAID POLYMERS MERCK PATENT GMBH (DE) 2015-03-12 US disclosed
CN-101970603-B Thermochromic composition and thermochromic microcapsules SAKURA COLOR PROD CORP 2014-04-23 CN disclosed
CN-101107260-B Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer SUMITOMO CHEMICAL CO.,LTD. (JP) 2012-02-08 CN disclosed
CN-101970603-A Thermochromic composition and thermochromic microcapsules SAKURA COLOR PROD CORP 2011-02-09 CN disclosed
CN-100446990-C Color developing agent for recording material ASAHI CHEMICAL CORP (JP) 2008-12-31 CN disclosed
CN-100423951-C Sensitizer dispersion, method for producing same, method for producing mixed dispersion for thermal recording body, and thermal recording body SANKO CO LTD (JP) 2008-10-08 CN disclosed
CN-100379580-C 1, 2-bis (3-methylphenoxy) ethane composition and thermal recording medium prepared by using the same SANKO CO LTD (JP) 2008-04-09 CN disclosed
CN-101107260-A Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer SUMITOMO CHEMICAL CO (JP) 2008-01-16 CN disclosed
CN-1812887-A Developer for recording materials ASAHI CHEMICAL CORP (JP) 2006-08-02 CN disclosed
CN-1795108-A Method for producing material containing sensitizer dispersed therein for thermal recording article and thermal recording article SANKO CO LTD (JP) 2006-06-28 CN disclosed
CN-1750939-A 1, 2-bis (3-methylphenoxy) ethane composition and thermal recording medium prepared by using the same SANKO CO LTD (JP) 2006-03-22 CN disclosed
CN-1318776-A Development composition and thermosensitive recording material MITSUI CHEMICALS INC (JP) 2001-10-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180066000-A1 Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes OCIAD2, OCIAD1, ICOSLG PNMT 149/4885NPC1 2551/4885RAB9A 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.